613 related articles for article (PubMed ID: 33013894)
21. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1.
Gieras A; Cejka P; Blatt K; Focke-Tejkl M; Linhart B; Flicker S; Stoecklinger A; Marth K; Drescher A; Thalhamer J; Valent P; Majdic O; Valenta R
J Immunol; 2011 May; 186(9):5333-44. PubMed ID: 21451110
[TBL] [Abstract][Full Text] [Related]
22. Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization.
Movérare R; Westritschnig K; Svensson M; Hayek B; Bende M; Pauli G; Sorva R; Haahtela T; Valenta R; Elfman L
Int Arch Allergy Immunol; 2002 Aug; 128(4):325-35. PubMed ID: 12218371
[TBL] [Abstract][Full Text] [Related]
23. Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy.
Flicker S; Linhart B; Wild C; Wiedermann U; Valenta R
Immunobiology; 2013 Jun; 218(6):884-91. PubMed ID: 23182706
[TBL] [Abstract][Full Text] [Related]
24. Cor a 1-reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen-associated food allergy to hazelnut.
Hofmann C; Scheurer S; Rost K; Graulich E; Jamin A; Foetisch K; Saloga J; Vieths S; Steinbrink K; Adler HS
J Allergy Clin Immunol; 2013 May; 131(5):1384-92.e6. PubMed ID: 23246018
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal IgE antibodies against birch pollen allergens: novel tools for biological characterization and standardization of allergens.
Kaul S; Scheurer S; Danz N; Schicktanz S; Vieths S; Hoffmann A
J Allergy Clin Immunol; 2003 Jun; 111(6):1262-8. PubMed ID: 12789227
[TBL] [Abstract][Full Text] [Related]
26. Immunoblotting in the diagnosis of cross-reactivity in children allergic to birch.
Cudowska B; Kaczmarski M; Restani P
Rocz Akad Med Bialymst; 2005; 50():268-73. PubMed ID: 16358981
[TBL] [Abstract][Full Text] [Related]
27. Reshaping the Bet v 1 fold modulates T(H) polarization.
Wallner M; Hauser M; Himly M; Zaborsky N; Mutschlechner S; Harrer A; Asam C; Pichler U; van Ree R; Briza P; Thalhamer J; Bohle B; Achatz G; Ferreira F
J Allergy Clin Immunol; 2011 Jun; 127(6):1571-8.e9. PubMed ID: 21420160
[TBL] [Abstract][Full Text] [Related]
28. Tackling Bet v 1 and associated food allergies with a single hybrid protein.
Hofer H; Asam C; Hauser M; Nagl B; Laimer J; Himly M; Briza P; Ebner C; Lang R; Hawranek T; Bohle B; Lackner P; Ferreira F; Wallner M
J Allergy Clin Immunol; 2017 Aug; 140(2):525-533.e10. PubMed ID: 27939703
[TBL] [Abstract][Full Text] [Related]
29. Humoral immune responses to recombinant tree pollen allergens (Bet v I and Bet v II) in mice: construction of a live oral allergy vaccine.
Vrtala S; Grote M; Ferreira F; Susani M; Stocker B; Kraft D; Valenta R
Int Arch Allergy Immunol; 1995; 107(1-3):290-4. PubMed ID: 7613152
[TBL] [Abstract][Full Text] [Related]
30. Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1.
Gafvelin G; Thunberg S; Kronqvist M; Grönlund H; Grönneberg R; Troye-Blomberg M; Akdis M; Fiebig H; Purohit A; Horak F; Reisinger J; Niederberger V; Akdis CA; Cromwell O; Pauli G; Valenta R; van Hage M
Int Arch Allergy Immunol; 2005 Sep; 138(1):59-66. PubMed ID: 16103688
[TBL] [Abstract][Full Text] [Related]
31. Chimeras of Bet v 1 and Api g 1 reveal heterogeneous IgE responses in patients with birch pollen allergy.
Gepp B; Lengger N; Bublin M; Hemmer W; Breiteneder H; Radauer C
J Allergy Clin Immunol; 2014 Jul; 134(1):188-94. PubMed ID: 24529686
[TBL] [Abstract][Full Text] [Related]
32. Analysis of epitope-specific immune responses induced by vaccination with structurally folded and unfolded recombinant Bet v 1 allergen derivatives in man.
Pree I; Reisinger J; Focke M; Vrtala S; Pauli G; van Hage M; Cromwell O; Gadermaier E; Egger C; Reider N; Horak F; Valenta R; Niederberger V
J Immunol; 2007 Oct; 179(8):5309-16. PubMed ID: 17911617
[TBL] [Abstract][Full Text] [Related]
33. Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice.
Hoflehner E; Hufnagl K; Schabussova I; Jasinska J; Hoffmann-Sommergruber K; Bohle B; Maizels RM; Wiedermann U
PLoS One; 2012; 7(6):e39409. PubMed ID: 22768077
[TBL] [Abstract][Full Text] [Related]
34. A hypoallergenic variant of the major birch pollen allergen shows distinct characteristics in antigen processing and T-cell activation.
Kitzmüller C; Wallner M; Deifl S; Mutschlechner S; Walterskirchen C; Zlabinger GJ; Ferreira F; Bohle B
Allergy; 2012 Nov; 67(11):1375-82. PubMed ID: 22973879
[TBL] [Abstract][Full Text] [Related]
35. Molecular cloning and characterization of a birch pollen minor allergen, Bet v 5, belonging to a family of isoflavone reductase-related proteins.
Karamloo F; Schmitz N; Scheurer S; Foetisch K; Hoffmann A; Haustein D; Vieths S
J Allergy Clin Immunol; 1999 Nov; 104(5):991-9. PubMed ID: 10550744
[TBL] [Abstract][Full Text] [Related]
36. Vig r 6, the cytokinin-specific binding protein from mung bean (Vigna radiata) sprouts, cross-reacts with Bet v 1-related allergens and binds IgE from birch pollen allergic patients' sera.
Guhsl EE; Hofstetter G; Hemmer W; Ebner C; Vieths S; Vogel L; Breiteneder H; Radauer C
Mol Nutr Food Res; 2014 Mar; 58(3):625-34. PubMed ID: 23996905
[TBL] [Abstract][Full Text] [Related]
37. Enlarging the toolbox for allergen epitope definition with an allergen-type model protein.
Berkner H; Seutter von Loetzen C; Hartl M; Randow S; Gubesch M; Vogel L; Husslik F; Reuter A; Lidholm J; Ballmer-Weber B; Vieths S; Rösch P; Schiller D
PLoS One; 2014; 9(10):e111691. PubMed ID: 25356997
[TBL] [Abstract][Full Text] [Related]
38. Immunologic characterization of monoclonal antibodies that modulate human IgE binding to the major birch pollen allergen Bet v 1.
Lebecque S; Dolecek C; Laffer S; Visco V; Denépoux S; Pin JJ; Guret C; Boltz-Nitulescu G; Weyer A; Valenta R
J Allergy Clin Immunol; 1997 Mar; 99(3):374-84. PubMed ID: 9058694
[TBL] [Abstract][Full Text] [Related]
39. IgE-cross-blocking antibodies to Fagales following sublingual immunotherapy with recombinant Bet v 1.
Grilo JR; Kitzmüller C; Aglas L; Sánchez Acosta G; Vollmann U; Ebner C; Horak F; Kinaciyan T; Radauer C; Ferreira F; Jahn-Schmid B; Bohle B
Allergy; 2021 Aug; 76(8):2555-2564. PubMed ID: 33724487
[TBL] [Abstract][Full Text] [Related]
40. Filling the Antibody Pipeline in Allergy: PIPE Cloning of IgE, IgG
Köhler VK; Crescioli S; Fazekas-Singer J; Bax HJ; Hofer G; Pranger CL; Hufnagl K; Bianchini R; Flicker S; Keller W; Karagiannis SN; Jensen-Jarolim E
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
